Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to ...

Tens of thousands of Kaiser Permanente workers in California and Hawaii have gone on strike, demanding safer staffing levels ...

As always, this year's HLTH conference brought a slew of announcements — from product launches to funding rounds to new partnerships. This list features short summaries for seven of the conference’s ...

CMS Administrator Dr. Mehmet Oz said that Medicaid’s rapid spending growth is unsustainable and criticized state financing ...

Marlow Hernandez, the founder and former CEO of Cano Health, was set to face a trial over allegations that he fraudulently enriched himself and his family while managing the senior-focused primary ...

On Wednesday, the Centers for Medicare & Medicaid Services launched a new initiative in tandem with the White House and HHS aimed at creating a more patient-centric healthcare ecosystem. As part of ...

As the mental health crisis in the U.S. grows, mental health professionals are increasingly struggling due to workforce shortages. More than half of therapists report having feelings of burnout. And ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

Women’s health took the main stage at the HLTH Conference in Las Vegas on Monday. During a panel discussion, moderator Jodi Neuhauser, founder and CEO of 51&, detailed how the women’s healthcare ...

The use of AI in healthcare is rapidly growing, but physicians are often left out of the conversation about how these technologies should be implemented effectively. That’s why the American Medical ...

Healthcare staff members are finding Artera’s AI copilots helpful and easy to use after six months of real-world deployment. Artera, a digital health software company based in Santa Barbara, launched ...